Arbutus Biopharma Corporation · NASDAQ:ABUS

Morgan Stanley reported a 8.80% stake in Arbutus Biopharma Corporation (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 12, 2026

Morgan Stanley reported a 8.80% stake in Arbutus Biopharma Corporation, 17,387,398 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).

Stake
8.80%
Shares
17,387,398
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley8.80%17,387,398
Morgan Stanley Investment Management Inc.8.70%17,122,142

Source

View original at SEC

Related